"Avoidable Deaths" - Union for International Cancer Control

"Back to Basics: The Concept of HRQL Under a Magnifying Glass" - EORTC Quality of Life Group

"Bald for a Cause" initiative - UWC Dilijan College

COTA has announced a partnership with precision oncology pioneer Guardant Health

Mia Levy: Foundation Medicine surpasses 1,000 peer-reviewed publications

Vincent Rajkumar: The 4 big myeloma randomized trials to watch out for ASCO24

Natasha Rekhtman: New Rare Type cell lung cancer identified by MSK Research Team

Neeraj Agarwal: Camrelizumab+apatinib in previously treated pts w/ advanced adrenocortical cancer by Zhigong Wei

SURE-02 Phase 2 Trial Interim Results: Neoadjuvant Sacituzumab Govitecan Plus Pembrolizumab Shows Promising Bladder Preservation in Muscle-Invasive Bladder Cancer